- Home
- IMUX vs KBSX Comparison
IMUX vs KBSX Comparison
Compare IMUX & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- KBSX
- Stock Information
- Founded
- IMUX 2016
- KBSX 1976
- Country
- IMUX United States
- KBSX Taiwan
- Employees
- IMUX N/A
- KBSX N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- KBSX Recreational Games/Products/Toys
- Sector
- IMUX Health Care
- KBSX Consumer Discretionary
- Exchange
- IMUX Nasdaq
- KBSX Nasdaq
- Market Cap
- IMUX 67.8M
- KBSX 80.6M
- IPO Year
- IMUX N/A
- KBSX N/A
- Fundamental
- Price
- IMUX $0.96
- KBSX $1.76
- Analyst Decision
- IMUX Strong Buy
- KBSX
- Analyst Count
- IMUX 5
- KBSX 0
- Target Price
- IMUX $7.50
- KBSX N/A
- AVG Volume (30 Days)
- IMUX 1.1M
- KBSX 40.6K
- Earning Date
- IMUX 08-11-2025
- KBSX 05-16-2025
- Dividend Yield
- IMUX N/A
- KBSX N/A
- EPS Growth
- IMUX N/A
- KBSX N/A
- EPS
- IMUX N/A
- KBSX N/A
- Revenue
- IMUX N/A
- KBSX $36,499,644.00
- Revenue This Year
- IMUX N/A
- KBSX N/A
- Revenue Next Year
- IMUX N/A
- KBSX N/A
- P/E Ratio
- IMUX N/A
- KBSX N/A
- Revenue Growth
- IMUX N/A
- KBSX 27.04
- 52 Week Low
- IMUX $0.56
- KBSX $1.26
- 52 Week High
- IMUX $2.11
- KBSX $15.48
- Technical
- Relative Strength Index (RSI)
- IMUX 55.60
- KBSX N/A
- Support Level
- IMUX $0.94
- KBSX N/A
- Resistance Level
- IMUX $1.18
- KBSX N/A
- Average True Range (ATR)
- IMUX 0.08
- KBSX 0.00
- MACD
- IMUX 0.01
- KBSX 0.00
- Stochastic Oscillator
- IMUX 40.95
- KBSX 0.00
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About KBSX FST Corp. Ordinary Shares
FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.